ACP supports updated naloxone guidance from AMA Opioid Task Force
The guidance encourages physicians to consider co-prescribing naloxone when it is clinically appropriate.
ACP is one of the many organizations supporting the AMA Opioid Task Force. The Task Force has released an updated guidance document encouraging physicians to consider co-prescribing naloxone when it is clinically appropriate. ACP had input into the document's development.
ACP called for the expansion of access to naloxone for opioid users, law enforcement, and emergency medical personnel in a recent position paper on substance use disorders.